仟源医药：自2024年公司开展线上业务以来，戒烟药酒石酸伐尼克兰片销量逐月稳步增长

Core Insights - The company, Qianyuan Pharmaceutical, reported a steady increase in sales of its smoking cessation drug, Varenicline Tartrate Tablets, since launching its online business in 2024 [2] - The online market share of the drug increased from 8% in the first half of 2024 to 24% in the first half of 2025, indicating significant growth [2] Company Performance - Qianyuan Pharmaceutical's online sales of Varenicline Tartrate Tablets have shown consistent month-over-month growth since the start of its online operations [2] - The increase in market share reflects the company's successful strategy in expanding its online presence and capturing a larger segment of the market [2]